PMU55 - CONSEQUENCES ON ECONOMIC OUTCOMES OF GENERIC VERSUS BRAND-NAME DRUGS USED IN ROUTINE CLINICAL PRACTICE- THE CASE OF TREATING PERIPHERAL NEUROPATHIC PAIN OR GENERALIZED ANXIETY DISORDER WITH PREGABALIN
Abstract
Authors
A. Sicras-Mainar J Rejas M. Perez-Paramo L. Sánchez-Alvarez R. Navarro-Artieda J Darba